Annabella is a technology company.
Annabella has raised $9.0M across 1 funding round.
Annabella has raised $9.0M in total across 1 funding round.
Annabella has raised $9.0M in total across 1 funding round.
Annabella's investors include ICON, Tamar Technology Ventures, Y Combinator, Adam Gross, Christian Bach, Ido Yablonka, Jeremy Stoppelman, Kevin Lin, Mathias Biilmann Christensen, Michael Stoppelman, Oren Dobronsky, Ran Makavy.
Annabella is a femtech company specializing in innovative breast pumps that mimic a baby's natural suckling motion using tongue-simulation technology, delivering up to 50% more milk expression efficiency and greater comfort compared to leading brands.[2][3][4] Founded in 2016 and based in West Palm Beach, Florida, it serves breastfeeding mothers worldwide, solving pain points in traditional pumping like discomfort and low yield through FDA-cleared, patented devices including single and double electric pumps, plus accessories.[1][2][4] The company has raised over $10.35M in funding, including an $8.5M seed round in 2024 supporting U.S. expansion, and reported 154% revenue growth to NIS 4.5M in H1 2025 from European, Israeli, and U.S. online sales.[1][2][4]
Annabella has captured 5-10% monthly market share in Israel since its 2023 launch there, sold over 4,000 units via retail, and holds 8 patents in breastfeeding tech while earning innovation awards.[1][3][4]
Annabella was founded in 2016 by Masha Waldberg (Founder & VP), Senia Waldberg (Founder & CMO), and Uri Yaffe (Founder & CEO), driven by a mission to empower mothers with superior femtech products that prioritize comfort and efficiency in breastfeeding.[3][4] The core idea emerged from addressing gaps in existing breast pumps, leading to patented technology that simulates a baby's tongue motion for a more natural experience.[2][5] Early traction built in Israel with a February 2023 retail launch via Shilav stores, achieving rapid 5-10% monthly market penetration and over 4,000 units sold, plus a Shark Tank feature.[3][4] Pivotal moments include FDA clearance, first patents in the US and China, Israel's fastest crowdfunding at $3M, and a major $8.5M seed round in 2024 fueling U.S. market entry.[1][2][4]
Annabella rides the booming femtech wave, targeting the $50B+ maternal health market with smart, app-integrated breastfeeding devices amid rising demand for portable, data-tracking wearables.[2] Timing aligns with post-pandemic focus on women's health tech, remote work enabling U.S./Europe expansion, and regulatory wins like FDA clearance accelerating adoption.[1][4] Favorable forces include aging millennial motherhood, e-commerce growth in baby products, and investor enthusiasm—evidenced by $10M+ funding and crowdfunding success—positioning Annabella to disrupt incumbents like Medela.[2][4] It influences the ecosystem by advancing connected pumps with real-time tracking and personalization, fostering innovation in babycare wearables.[2]
Annabella's trajectory points to scaled U.S. dominance, with H1 2025's 154% growth signaling potential for multi-fold revenue in 2026 via expanded double-pump lines and accessories.[1] Trends like AI-personalized femtech, global e-commerce penetration, and wearables integration will propel it, possibly eyeing Series A or acquisitions by medtech giants. Its influence could redefine breastfeeding standards, empowering more mothers—building on early wins to claim a lasting slice of the maternal wellness revolution.[2][4]
Annabella has raised $9.0M across 1 funding round. Most recently, it raised $9.0M Seed in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2024 | $9.0M Seed | ICON, Tamar Technology Ventures, Y Combinator, Adam Gross, Christian Bach, Ido Yablonka, Jeremy Stoppelman, Kevin Lin, Mathias Biilmann Christensen, Michael Stoppelman, Oren Dobronsky, Ran Makavy |